Caxton Associates (UK)’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-53,257
Closed -$569K 822
2025
Q4
$569K Buy
53,257
+15,768
+42% +$173K 0.01% 477
2025
Q3
$467K Sell
37,489
-1,054
-3% -$10.8K 0.01% 473
2025
Q2
$394K Hold
38,543
0.01% 480
2025
Q1
$304K Buy
+38,543
New +$474K 0.01% 627

Other funds holding CRNC

Caxton Associates (UK)'s CRNC Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Cerence (CRNC) in Q1 2026, closing a stake of 53,257 shares — an estimated $569K sold.

Caxton Associates (UK) first reported a position in CRNC in Q1 2025 and held it in 4 quarters. The position peaked at $569K in Q4 2025. 195 funds tracked by Wall St. Rank hold CRNC as of Q1 2026.

  • Caxton Associates (UK) reported no remaining Cerence position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 53,257 Cerence shares in Q1 2026, an estimated $569K.
  • Caxton Associates (UK) first reported a position in Cerence in Q1 2025 and held it in 4 quarters.
  • Caxton Associates (UK)'s Cerence position peaked at $569K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Cerence as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.